ANI Pharmaceuticals Inc  

(Public, NASDAQ:ANIP)   Watch this stock  
Find more results for NASDAQ:BPAX
57.11
+3.42 (6.37%)
Real-time:   9:51AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 55.97 - 57.61
52 week 19.51 - 61.43
Open 56.00
Vol / Avg. 50,269.00/265,544.00
Mkt cap 646.40M
P/E 55.29
Div/yield     -
EPS 1.03
Shares 11.32M
Beta 2.40
Inst. own 76%
Nov 3, 2014
Q1 2014 ANI Pharmaceuticals Inc Earnings Call
Nov 3, 2014
Q3 2014 ANI Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 38.80% 0.35%
Operating margin 47.16% 2.99%
EBITD margin - 6.68%
Return on average assets 26.65% 0.36%
Return on average equity 27.96% -
Employees 81 -
CDP Score - -

Address

210 MAIN STREET WEST
BAUDETTE, MN 56623
United States - Map
+1-218-6343500 (Phone)
+1-218-6343540 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173, 00 square feet, the Company manufactures oral solid dose products, as well as liquids and topicals, including narcotics. The Company performs contract manufacturing for other pharmaceutical companies. It has launched three products and has 11 products in development. The Company�s targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities. The Company is positioned to develop and manufacture niche oncolytic (anti-cancer) drugs due to the capabilities of the Company's containment facility and its expertise in manufacturing segregation.

Officers and directors

Robert E. Brown Jr. Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Arthur S. Przybyl President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Charlotte C. Arnold Chief Financial Officer, Vice President
Age: 51
Bio & Compensation  - Reuters
James G. Marken Vice President - Operations
Age: 51
Bio & Compensation  - Reuters
Robert J. Jamnick Vice President - Quality and Product Development
Age: 56
Bio & Compensation  - Reuters
Robert W. Schrepfer Vice President - New Business Development and Contract Manufacturing
Age: 42
Bio & Compensation  - Reuters
Thomas A. Penn Director
Age: 68
Bio & Compensation  - Reuters
Fred H. Holubow Independent Director
Age: 75
Bio & Compensation  - Reuters
Ross J. Mangano Independent Director
Age: 68
Bio & Compensation  - Reuters
Tracy L. Marshbanks Ph.D. Independent Director
Age: 50
Bio & Compensation  - Reuters